LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq: RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its financial results for this period in a press release to be issued before the market opens on Thursday, November 4, 2010.
